Works matching DE "ANTIOBESITY agents"
Results: 1255
Polycystic Ovary Syndrome and Obesity: A Cross-Sectional Survey of Patients and Obstetricians/Gynecologists.
- Published in:
- Journal of Women's Health (15409996), 2023, v. 32, n. 6, p. 723, doi. 10.1089/jwh.2022.0471
- By:
- Publication type:
- Article
Obesity in Women: Insights for the Clinician.
- Published in:
- Journal of Women's Health (15409996), 2018, v. 27, n. 4, p. 444, doi. 10.1089/jwh.2016.6196
- By:
- Publication type:
- Article
Microneedle Patch Delivery of Capsaicin‐Containing α‐Lactalbumin Nanomicelles to Adipocytes Achieves Potent Anti‐Obesity Effects.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 20, p. 1, doi. 10.1002/adfm.202011130
- By:
- Publication type:
- Article
The central administration of C75, a fatty acid synthase inhibitor, activates sympathetic outflow and thermogenesis in interscapular brown adipose tissue.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2013, v. 465, n. 12, p. 1687, doi. 10.1007/s00424-013-1301-5
- By:
- Publication type:
- Article
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 5, p. 669, doi. 10.1007/s00228-024-03646-0
- By:
- Publication type:
- Article
Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 11, p. 1611, doi. 10.1007/s00228-021-03160-7
- By:
- Publication type:
- Article
Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 7, p. 817, doi. 10.1007/s00228-015-1868-1
- By:
- Publication type:
- Article
Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM).
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 7, p. 653, doi. 10.1007/s00228-011-1038-z
- By:
- Publication type:
- Article
Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 3, p. 215, doi. 10.1007/s00228-010-0981-4
- By:
- Publication type:
- Article
Incorrect use of orlistat and sibutramine in clinical practice.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 2, p. 205, doi. 10.1007/s00228-006-0226-8
- By:
- Publication type:
- Article
Press coverage and sales of Xenical in Sweden, 1998–2000.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 4, p. 285, doi. 10.1007/s00228-005-0914-9
- By:
- Publication type:
- Article
Novel Oral Antiobesity Drug Reduces Body Weight by up to 13%: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 4
- By:
- Publication type:
- Article
Adults with Prior Antiobesity Medication Use Before Semaglutide Use Lose More Weight: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 2
- Publication type:
- Article
Navigating the New Wave of Antiobesity Medications: What Primary Care Clinicians Should Know.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Novel Antiobesity Drug Significantly Improves Body Composition, Bone Mineral Content in Phase 2 Study.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Obesity Care Needs More Cardiology Support, Suggest 2 New Studies.
- Published in:
- Patient Care (Online), 2024, p. 3
- By:
- Publication type:
- Article
Viking Therapeutics Oral Antiobesity Agent Returns Positive Results in Small Study.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
First Issue of Patient Care Online Digital Edition Goes Live.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Novo Nordisk Shares Early Findings for Novel Oral Antiobesity Agent.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Semaglutide 2.4 mg (Wegovy) Wins Expanded Indication to Include Reduced Risk of MACE.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Novo Nordisk Shares Early Findings for Novel Oral Antiobesity Agent.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Where is All the Wegovy Going?
- Published in:
- Patient Care (Online), 2024, p. 2
- By:
- Publication type:
- Article
Weight Management Treatments Underused among Primary Care Patients with Obesity: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
13 Drugs Approved for Primary Care in 2023.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Where is All the Wegovy Going? Highest and Lowest Prescribing States.
- Published in:
- Patient Care (Online), 2024, p. 1
- Publication type:
- Article
Nonprescription Weight Loss Products Used by 1 in 10 Adolescents Worldwide: New Meta-Analysis.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
"Ozempic" and Older Adults: Awareness of & Views on Rx Medications for Weight Management.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Nonprescription Weight Loss Products Used by 1 in 10 Adolescents Worldwide: New Meta-Analysis.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Nonprescripton Weight Loss Products Used by 1 in 10 Adolescents Worldwide: New Meta-Analysis.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Advancements in Obesity Medicine in 2023: Breakthroughs and Shifting Perspectives on Treatment.
- Published in:
- 2024
- By:
- Publication type:
- Interview
Letter to the Editor from R. McCallum: "Weight Loss From Combination Anti-Obesity Medication Regimens Can Approach That Achieved From Bariatric Surgery".
- Published in:
- 2023
- By:
- Publication type:
- Letter
Anti-obesity Drugs for the Treatment of Binge Eating Disorder: Opportunities and Challenges.
- Published in:
- Alpha Psychiatry, 2024, v. 25, n. 3, p. 312, doi. 10.5152/alphapsychiatry.2024.241464
- By:
- Publication type:
- Article
Acute Hepatitis Following the Use of a Slimming Pill Containing Herbal Elements.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
A ATUAÇÃO DO FARMACÊUTICO NO USO INDISCRIMINADO DE MEDICAMENTOS PARA EMAGRECIMENTO E SUAS PRINCIPAIS REAÇÕES ADVERSAS.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2024, v. 17, n. 11, p. 1, doi. 10.54751/revistafoco.v17n11-126
- By:
- Publication type:
- Article
New pharmacological treatments for obesity: Incretin analogues, their mechanism of action, efficacy and safety.
- Published in:
- Medicine Today, 2024, v. 25, n. 10, p. 59
- By:
- Publication type:
- Article
Skeletal fragility in type 2 diabetes: Assessment and management.
- Published in:
- Medicine Today, 2024, v. 25, n. 7, p. 18
- By:
- Publication type:
- Article
Medicare Should Cover Weight Loss Drugs as Long as the Prices are Affordable.
- Published in:
- Journal of Law, Medicine & Ethics, 2024, v. 52, n. 1, p. 188, doi. 10.1017/jme.2024.56
- By:
- Publication type:
- Article
A Track from Diet Pills and Laxatives to an Eating Disorder.
- Published in:
- Eating Disorders Review, 2021, v. 32, n. 3, p. N.PAG
- Publication type:
- Article
FDA Committee Reviews Orlistat as an Over-the-Counter Agent.
- Published in:
- Eating Disorders Review, 2006, v. 17, n. 1, p. 1
- By:
- Publication type:
- Article
Orlistat Plus Metformin: An Effective Combination?
- Published in:
- Eating Disorders Review, 2004, v. 15, n. 6, p. 3
- Publication type:
- Article
Comparison of Cell-Free Extracts from Three Newly Identified Lactobacillus plantarum Strains on the Inhibitory Effect of Adipogenic Differentiation and Insulin Resistance in 3T3-L1 Adipocytes.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6676502
- By:
- Publication type:
- Article
Characterization of Some Plant Extracts, Piperine, and Piperic Acid and Their Anti-Obesity and Anti-Acne Effects Through the In Vitro Inhibition of Pancreatic and Bacterial Lipases.
- Published in:
- Catalysts (2073-4344), 2024, v. 14, n. 11, p. 776, doi. 10.3390/catal14110776
- By:
- Publication type:
- Article
New Intensification Strategies for the Direct Conversion of Real Biomass into Platform and Fine Chemicals: What Are the Main Improvable Key Aspects?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Substance Use in the Transgender Population: A Meta-Analysis.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 3, p. 366, doi. 10.3390/brainsci12030366
- By:
- Publication type:
- Article
Inhibitory Potential of Synthetic Amino Acid Derivatives against Digestive Enzymes as Promising Hypoglycemic and Anti-Obesity Agents.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 953, doi. 10.3390/biom13060953
- By:
- Publication type:
- Article
Commentary: Shared decision making for weight‐lowering medications in China.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 11, p. 1, doi. 10.1002/ctm2.70065
- By:
- Publication type:
- Article
Effects of 6 months of aerobic and resistance exercise training on carotid artery intima media thickness in overweight and obese older women.
- Published in:
- Geriatrics & Gerontology International, 2017, v. 17, n. 12, p. 2304, doi. 10.1111/ggi.12972
- By:
- Publication type:
- Article
CB<sub>1</sub>-independent mechanisms of Δ<sup>9</sup>-THCV, AM251 and SR141716 (rimonabant).
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 3, p. 260, doi. 10.1111/j.1365-2710.2011.01284.x
- By:
- Publication type:
- Article
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2011, v. 36, n. 1, p. 10, doi. 10.1111/j.1365-2710.2010.01164.x
- By:
- Publication type:
- Article
Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.891512
- By:
- Publication type:
- Article